Clinical and Population Studies |
From the Laboratory of Biochemical Genetics and Metabolism (R.B., E.E.K., J.K.L., A.B., R.J., M.N., J.L.B.), the Laboratory of Molecular Genetics (J.S., J.M.F.), Howard Hughes Medical Institute (J.M.F.), The Rockefeller University, New York; the Broad Institute of Harvard and MIT (J.K.L., J.B.M., M.J.D., D.A.), Cambridge, Mass; the Department of Computer Science (I.P.), Columbia University, New York; the Center for Human Genetics Research (J.B.M., M.J.D.) and the Department of Molecular Biology (D.A., J.K.L.), Massachusetts General Hospital, Boston; the Department of Medicine (M.J.D., D.A.) and the Department of Genetics (D.A.), Harvard Medical School, Boston, Mass; and the Institute of Molecular Systems Biology (M.S.), ETH Zurich, Switzerland.
Correspondence to Jan L. Breslow, Laboratory of Biochemical Genetics, The Rockefeller University, 1230 York Avenue, New York, NY 10065. E-mail breslow{at}rockefeller.edu
Background— Variation in LDL-cholesterol (LDL-C) among individuals is a complex genetic trait involving multiple genes and gene-environment interactions.
Methods and Results— In a genome-wide association study (GWAS) to identify genetic variants influencing LDL-C in an isolated population from Kosrae, we observed associations for SNPs in the gene encoding 3hydroxy-3-methylglutaryl (HMG)-coenzyme A (CoA) reductase (HMGCR). Three of these SNPs (rs7703051, rs12654264, and rs3846663) met the statistical threshold of genome-wide significance when combined with data from the Diabetes Genetics Initiative GWAS. We followed up the association results and identified a functional SNP in intron13 (rs3846662), which was in linkage disequilibrium with the SNPs of genome-wide significance and affected alternative splicing of HMGCR mRNA. In vitro studies in human lymphoblastoid cells demonstrated that homozygosity for the rs3846662 minor allele was associated with up to 2.2-fold lower expression of alternatively spliced HMGCR mRNA lacking exon13, and minigene transfection assays confirmed that allele status at rs3846662 directly modulated alternative splicing of HMGCR exon13 (42.9±3.9 versus 63.7±1.0%
exon13/total HMGCR mRNA, P=0.02). Further, the alternative splice variant could not restore HMGCR activity when expressed in HMGCR deficient UT-2 cells.
Conclusion— We identified variants in HMGCR that are associated with LDL-C across populations and affect alternative splicing of HMGCR exon13.
In a genome-wide association study we identified variants in the HMG-CoA reductase gene that were associated with LDL-C across populations. Further, functional studies revealed that a common intronic SNP (rs384662) that is in linkage disequilibrium with the variants typed in the genome scan modulates alternative splicing of HMGCR mRNA.
Key Words: HMG-CoA reductase SNP genome-wide association study LDL-C alternative splicing
This article has been cited by other articles:
![]() |
E. E. Kenny, A. Gusev, K. Riegel, D. Lutjohann, J. K. Lowe, J. Salit, J. B. Maller, M. Stoffel, M. J. Daly, D. M. Altshuler, et al. Systematic haplotype analysis resolves a complex plasma plant sterol locus on the Micronesian Island of Kosrae PNAS, August 18, 2009; 106(33): 13886 - 13891. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |